Table 4.
MicroRNAa | Normal
|
22q11.2 Δ
|
Associative p-valueb | Ratiod | MiR regulatory functions | |||
---|---|---|---|---|---|---|---|---|
Average | SD | Average | SD | |||||
Congenital heart disease | miR-185 | 7655 | 2810 | 2841 | 1309 | 0.00E+00c | 0.37 | Mammalian organogenesis |
miR-15b-3p | 35 | 33 | 119 | 100 | 0.00E+00c | 3.41 | Cardiomyocyte mitotic arrest | |
miR-150 | 12,808 | 11,015 | 5494 | 3006 | 2.48E−10 | 0.43 | Cardiomyocyte cell growth | |
miR-720 | 851 | 993 | 342 | 210 | 2.19E−09 | 0.40 | Epithelial cell development | |
miR-194 | 134 | 102 | 262 | 182 | 8.13E−08 | 1.96 | Epithelial cell differentiation | |
miR-324-5p | 182 | 65 | 342 | 290 | 1.22E−07 | 1.88 | Hedgehog signaling | |
let-7b | 3722 | 4770 | 1334 | 803 | 3.51E−07 | 0.36 | Cell survival | |
miR-363 | 650 | 364 | 1044 | 563 | 2.75E−05 | 1.61 | Cardiomyocyte apoptosis | |
let-7 g | 3122 | 2486 | 1849 | 896 | 3.25E−04 | 0.59 | Heart development | |
let-7i | 3368 | 2217 | 2088 | 1248 | 5.54E−04 | 0.62 | Heart development | |
miR-23b | 1039 | 490 | 1583 | 712 | 7.52E−04 | 1.52 | Morphogenesis | |
miR-361-5p | 188 | 87 | 297 | 208 | 3.90E−03 | 1.58 | Chronic heart failure marker | |
Hypocalcemia | miR-185 | 7655 | 2810 | 2889 | 1380 | 0.00E+00b | 0.38 | Cell cycle and DNA methylation |
miR-150 | 12,808 | 11,015 | 5061 | 2793 | 1.09E−12 | 0.40 | Cell cycle signaling | |
miR-15b-3p | 35 | 33 | 124 | 114 | 6.91E−11 | 3.54 | Cellular ATP levels | |
miR-21 | 41 | 53 | 169 | 286 | 1.16E−09 | 4.09 | Cell proliferation | |
miR-324-5p | 182 | 65 | 343 | 246 | 2.01E−09 | 1.88 | As above | |
let-7b | 3722 | 4770 | 1467 | 730 | 1.64E−04 | 0.39 | As above | |
miR-720 | 851 | 993 | 326 | 233 | 4.29E−07 | 0.38 | As above | |
miR-194 | 134 | 102 | 268 | 193 | 1.85E−06 | 2.01 | As above | |
let-7i | 3368 | 2217 | 2098 | 1032 | 3.50E−03 | 0.62 | As above | |
miR-145 | 55 | 33 | 35 | 17 | 3.44E−03 | 0.63 | Smooth muscle cell function | |
Low CD3+ T cell counte | miR-185 | 7655 | 2810 | 2981 | 1317 | 0.00E+00b | 0.39 | B cell autoantibody production |
miR-15b-3p | 35 | 33 | 119 | 107 | 1.07E−11 | 3.41 | Cell survival | |
miR-324-5p | 182 | 65 | 365 | 260 | 6.46E−11 | 2.00 | As above | |
miR-21 | 41 | 53 | 181 | 292 | 1.90E−09 | 4.36 | Immune activation and tolerance | |
miR-150 | 12,808 | 11,015 | 6336 | 3198 | 3.66E−08 | 0.49 | T and B cell development | |
miR-720 | 851 | 993 | 320 | 236 | 7.19E−07 | 0.38 | As above | |
miR-194 | 134 | 102 | 254 | 179 | 7.00E−06 | 1.90 | Follicular lymphoma cell growth | |
let-7b | 3722 | 4770 | 1347 | 804 | 3.76E−05 | 0.36 | IFN-beta production | |
miR-29a | 17 | 11 | 36 | 38 | 5.89E−05 | 2.06 | IFN-gamma production | |
miR-361-5p | 188 | 87 | 317 | 235 | 4.58E−04 | 1.69 | Deregulated in blood cells |
MicroRNA refers to human microRNAs and let represents an early miR designation.
Associative p values.
Associative p-value is less than 10−12.
Ratio is the normal miR level divided by the 22q11.2 deletion syndrome miR levels.
Low CD3 levels are defined to be less than 2 SD compared with age-matched controls.